The Pulmonary Protection Trial
- Conditions
- Chronic Obstructive Lung Disease
- Interventions
- Drug: HTK CustodiolOther: Standard ECCProcedure: Perfusion of the lungs
- Registration Number
- NCT01614951
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
The purpose of this study is to investigate whether patients with a preoperative reduced pulmonary function have a better preserved oxygenation capacity after open heart surgery, using either pulmonary perfusion or pulmoplegia compared with TAVI and the control-group with standard ECC (Extra Corporal Circulation).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
-
Planned and urgent surgery on legally competent patients over 18 years:
- Coronary Artery Bypass Graft Surgery
- Aortic Valve Replacement
- Coronary Artery Bypass Graft Surgery + Aortic Valve Replacement
- Transcatheter Aortic-Valve Implantation
-
Spirometry FEV1 measurement show less than or equal to 80% of the anticipated. We expect that these patients provide the largest signal with lung protective interventions in relation to lung healthy patients.
- Previous surgery on the heart or lungs
- Previous thoracic irradiation
- Preoperative heart failure (ejection fraction below 20%).
- Surgical demanding mitral regurgitation
- Unstable patients (heart rate above 100 and systolic blood pressure below 100 mmHg)
- Intubated patients
- Patients with an ongoing preoperative treatment with antibiotics for suspected pneumonia.
- Patients with renal insufficiency requiring hemodialysis
- Pregnant and lactating
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pulmoplegia HTK Custodiol - Control group Standard ECC - Pulmonary perfusion Perfusion of the lungs -
- Primary Outcome Measures
Name Time Method Oxygenation Index From pre operation until 24 hours post operation To investigate whether patients with a preoperative reduced pulmonary function have a better preserved oxygenation index after open heart surgery, using either pulmonary perfusion or pulmoplegia compared with TAVI and the control-group with standard ECC (Extra Corporal Circulation).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Rigshospitalet
🇩🇰Copenhagen N, Denmark